Learn More
Selleck Chemical LLC TAK-285 S2784-5mg

Supplier: Selleck Chemical LLC S27845MG
TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM 10-fold selectivity for HER1/2 than HER4 less potent to MEK1/5 c-Met Aurora B Lck CSK etc Phase 1
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.